<- Back

Opioid Induced Constipation QI Program

  • : Melbourne VIC 3000
QI Program aim

This Quality Improvement (QI) Program aims to improve the management and quality of life in patients taking opioids and experiencing constipation.

Learning objectives

By completing this learning activity, participants will be able to:

  • Know how to diagnose OIC (including an awareness of the barriers to diagnosis) and assess the severity and impacts of OIC.
  • Recognise the importance of non-pharmacological approaches to managing OIC. 
  • Understand the importance of taking a laxative use history and monitoring laxative use in patients with OIC.
  • Undertake opioid-switching, and understand the efficacy and safety of opioid receptor antagonists in the management of OIC.
  • Make treatment choices based on best practice and available evidence, and ensure patient safety by regular review and monitoring.

This activity is sponsored by Mundipharma.

Why take part in this program?

Inclusion criteria

How long should it take?

Steps to proceed

Content partners: 

Mundipharma

Category: 

Pain management

Components
Opioid Induced Constipation – Pre-Test
Opioid Induced Constipation - Declaration
Opioid Induced Constipation – Patient Entry
Opioid Induced Constipation – Management Review
Opioid Induced Constipation - Evaluation
Title
Opioid Induced Constipation QI Program
Speciality Classification
Interest Areas / Topics Covered
-- GENERAL --
Location
Type
Delivery
Provider Type
RTO
CPD
RACGP 40 CPD, ACRRM 30 CME PD
Price
0.00
Location
Melbourne VIC 3000
Posted By
Contact Phone
Log in into view this field.
17 Views
Similar Courses and Events
HealthcareLink